Healthcare entity
Every one of those 1 sits in a single category, regulation. Drugs for Neglected Diseases initiative (DNDi) is most often covered alongside Acoziborole, which appears in 1 of these 1 story. At 8, the average consequence score sits above the same-window beat average of 5.9.
Last mentioned: Mar 16, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Drugs for Neglected Diseases initiative (DNDi) is most often covered alongside Acoziborole, which appears in 1 of these 1 story. At 8, the average consequence score sits above the same-window beat average of 5.9. Source depth averages 2 original sources per story, versus 4.3 across the same-window beat baseline. Drugs for Neglected Diseases initiative (DNDi) appears in 1 tracked Healthcare story from March 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Drugs for Neglected Diseases initiative (DNDi). Shared-story counts are live from our verified record — not editorial picks.
Rollout Milestone
Acoziborole enters the final stages of regulatory rollout for endemic regions.
Trial Results
Phase 2/3 clinical trial results for Acoziborole show high efficacy.
Fexinidazole Approval
First all-oral 10-day treatment for sleeping sickness is approved.
Research Begins
DNDi starts screening compounds for a single-dose HAT treatment.
The introduction of Acoziborole, a single-dose oral medication, marks a pivotal shift in the global fight against Human African Trypanosomiasis. This breakthrough treatment simplifies complex therapeutic regimens, potentially enabling the total elimination of the disease by 2030.
Drugs for Neglected Diseases initiative (DNDi) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
